We are delighted to share an outstanding achievement by our esteemed Principal Investigator, Associate Prof. Dr. Wan Zamaniah, and her dedicated Study Coordinator, Ms. Wei Ying, for the CLARITY Study (D9800C00001).
Malaysia’s First Subject Randomized!
Their unwavering dedication has led to the successful enrollment and randomization of the first subject in Malaysia for the CLARITY study. This significant milestone not only showcases the team’s commitment to excellence but also paves the way for further advancements in clinical research.
This achievement highlights the pivotal role CIC UMMC plays in driving innovative clinical studies. We look forward to seeing how these efforts will contribute to improved patient care and medical breakthroughs.
Let’s continue to build on this success!
Stay tuned for more updates from the CLARITY Study and our other transformative projects!
#ClinicalResearch #CLARITYStudy #MalaysiaMilestone #CICUMMC #InnovationInMedicine #LeaderInClinicalTrials
CIC Webinar: Essential Updates on ICH GCP E6 (R3) Guidelines
We are delighted to announce the successful completion of our webinar, “Essential Updates on ICH GCP E6 (R3) Guidelines: Practical Insights for Clinical Research Teams,”